联影医疗 - Financials

联影医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
+Revenue	10.3B	11.4B	9.2B	7.3B	5.8B	3.0B	2.0B
Revenue Growth %	-9.7%	23.5%	27.4%	25.9%	93.4%	46.4%	--
Total Revenue	10.3B	11.4B	9.2B	7.3B	5.8B	3.0B	2.0B
Cost Of Revenue	5.3B	6.0B	4.8B	3.7B	3.0B	1.7B	1.2B
+Gross Profit	5.0B	5.4B	4.5B	3.6B	2.8B	1.2B	795.0M
Gross Margin %	48.5%	47.1%	48.4%	49.4%	48.6%	41.8%	39.1%
Total Operating Cost	9.5B	10.0B	7.9B	6.0B	5.0B	3.4B	2.6B
Selling Expenses	1.8B	1.6B	1.3B	1.0B	756.0M	694.0M	472.0M
Admin Expenses	556.0M	561.0M	431.0M	319.0M	390.0M	205.0M	177.0M
Rd Expenses	1.8B	1.7B	1.3B	968.0M	756.0M	579.0M	551.0M
Finance Expenses	-112.0M	-149.0M	-98.7M	-24.4M	24.3M	39.7M	34.2M
+Operating Income	1.4B	2.1B	1.9B	1.7B	1.2B	-23.0M	-186.0M
Operating Margin %	13.3%	18.8%	20.9%	23.4%	20.5%	-0.8%	-9.1%
Non Operating Income	5.5M	10.5M	2.4M	10.5M	9.1M	9.8M	10.6M
Non Operating Expenses	20.2M	9.8M	10.9M	9.1M	34.9M	8.6M	3.9M
Investment Income	98.1M	110.0M	12.7M	62.2M	28.8M	21.4M	102.0M
Fair Value Change Income	37.0M	-6.1M	28.5M	-10.6M	4.9M	817,500	20,200
Asset Disposal Income	-869,800	13,500	-600.00	-174,600	84,100	27.5M	93,100
Asset Impairment Loss	-13.8M	42.9M	74.7M	25.2M	6.7M	46.7M	48.8M
Other Income	444.0M	586.0M	592.0M	440.0M	348.0M	307.0M	233.0M
Income Before Tax	1.4B	2.1B	1.9B	1.7B	1.2B	-21.8M	-179.0M
Income Tax	110.0M	164.0M	270.0M	294.0M	218.0M	26.3M	-47.3M
+Net Income	1.2B	2.0B	1.6B	1.4B	937.0M	-48.0M	-132.0M
Net Margin %	12.1%	17.3%	17.9%	19.4%	16.3%	-1.6%	-6.5%
Net Income Attributable	1.3B	2.0B	1.7B	1.4B	903.0M	-73.5M	-126.0M
Minority Interest	-19.9M	3.5M	-6.0M	-13.7M	33.7M	25.5M	-6.3M
Eps Basic	1.54	2.40	2.19	1.96	1.30	--	--
Eps Diluted	1.54	2.40	2.19	1.96	1.30	--	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
Cash And Equivalents	8.4B	7.6B	10.1B	2.9B	3.2B	1.8B	2.0B
Trading Financial Assets	1.7B	4.9B	4.0B	--	6.2M	--	8.0M
Accounts Receivable	4.4B	3.2B	2.0B	1.0B	655.0M	897.0M	838.0M
Notes Receivable	1.1M	4.9M	16.2M	14.7M	20.1M	4.7M	30.4M
Notes And Accounts Receivable	4.4B	3.2B	2.0B	1.1B	675.0M	901.0M	868.0M
Prepayments	196.0M	148.0M	198.0M	124.0M	68.2M	51.3M	24.3M
Inventory	5.5B	3.9B	3.5B	2.2B	1.8B	1.6B	1.3B
Total Current Assets	20.9B	20.2B	20.1B	7.0B	6.1B	4.6B	4.6B
Long Term Equity Investment	188.0M	73.4M	40.0M	44.5M	51.6M	36.7M	3.5M
Fixed Assets	--	2.2B	2.1B	2.0B	2.0B	1.3B	890.0M
Fixed Assets Total	2.9B	2.2B	2.1B	2.0B	2.0B	1.3B	890.0M
Construction In Progress	--	850.0M	222.0M	10.8M	--	433.0M	322.0M
Construction In Progress Total	1.8B	850.0M	222.0M	10.8M	--	433.0M	322.0M
Intangible Assets	1.0B	828.0M	860.0M	608.0M	530.0M	461.0M	469.0M
Long Term Deferred Expenses	67.9M	74.5M	81.7M	83.3M	94.7M	1.3M	3.1M
Total Non Current Assets	7.1B	5.1B	4.1B	3.3B	3.5B	3.2B	2.3B
Total Assets	28.0B	25.3B	24.2B	10.4B	9.7B	7.8B	6.9B
Short Term Borrowings	557.0M	9.2M	15.6M	29.7M	587.0M	1.4B	1.1B
Accounts Payable	2.1B	1.6B	1.9B	1.1B	863.0M	532.0M	457.0M
Advance Receipts	--	--	--	--	--	1.2B	952.0M
Contract Liabilities	2.1B	2.3B	2.4B	2.2B	2.3B	--	--
Total Current Liabilities	7.1B	5.8B	6.0B	4.5B	4.8B	4.0B	3.3B
Long Term Borrowings	--	--	--	--	--	320.0M	390.0M
Total Non Current Liabilities	1.1B	657.0M	719.0M	811.0M	1.3B	1.4B	1.2B
Total Liabilities	8.1B	6.5B	6.7B	5.3B	6.0B	5.4B	4.5B
Paid In Capital	824.0M	824.0M	824.0M	724.0M	724.0M	690.0M	690.0M
Capital Reserve	13.9B	13.9B	13.9B	3.2B	3.2B	3.5B	3.5B
Surplus Reserve	412.0M	412.0M	408.0M	230.0M	73.5M	--	--
Retained Earnings	5.2B	4.2B	2.4B	934.0M	-326.0M	-1.9B	-1.9B
Minority Equity	3.1M	15.1M	-9.8M	-3.8M	9.9M	180.0M	153.0M
Equity Attributable	19.9B	18.9B	17.5B	5.0B	3.6B	2.2B	2.3B
Total Equity	19.9B	18.9B	17.5B	5.0B	3.6B	2.4B	2.5B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
Cash From Sales	10.5B	11.0B	10.0B	7.9B	8.2B	3.7B	2.8B
Tax Refunds Received	483.0M	454.0M	319.0M	254.0M	325.0M	170.0M	335.0M
Total Operating Cash Inflow	11.3B	12.1B	10.7B	8.3B	8.8B	4.2B	3.4B
Cash Paid For Goods	6.9B	7.2B	6.6B	4.8B	3.3B	2.2B	1.9B
Cash Paid To Employees	2.9B	2.7B	2.0B	1.5B	1.1B	1.0B	754.0M
Taxes Paid	866.0M	1.0B	700.0M	494.0M	584.0M	285.0M	204.0M
Total Operating Cash Outflow	11.9B	12.0B	10.0B	7.4B	5.5B	4.0B	3.2B
Operating Cash Flow	-619.0M	133.0M	683.0M	942.0M	3.3B	258.0M	212.0M
Total Investing Cash Inflow	27.0B	25.5B	7.2B	10.3B	11.3B	8.6B	9.6B
Total Investing Cash Outflow	28.2B	27.0B	11.9B	10.6B	11.7B	9.6B	10.0B
Investing Cash Flow	-1.2B	-1.6B	-4.7B	-254.0M	-377.0M	-927.0M	-432.0M
Cash From Borrowings	555.0M	17.3M	17.2M	30.0M	1.1B	1.8B	1.1B
Dividends And Interest Paid	304.0M	166.0M	956,800	8.1M	56.7M	77.5M	62.3M
Debt Repayments	9.5M	13.2M	32.2M	586.0M	2.4B	1.6B	685.0M
Total Financing Cash Inflow	649.0M	27.6M	10.8B	73.2M	1.3B	2.1B	1.2B
Total Financing Cash Outflow	450.0M	690.0M	84.2M	1.0B	2.6B	1.9B	747.0M
Financing Cash Flow	199.0M	-662.0M	10.7B	-935.0M	-1.3B	268.0M	489.0M
Net Change In Cash	-1.7B	-2.1B	6.8B	-252.0M	1.6B	-401.0M	266.0M
Ending Cash Balance	5.9B	7.5B	9.6B	2.9B	3.1B	1.5B	1.9B
Capex	1.9B	1.1B	741.0M	347.0M	703.0M	649.0M	561.0M